M. Binnewies, E. W. Roberts, K. Kersten, V. Chan, D. F. Fearon et al., Understanding the tumor immune microenvironment (TIME) for effective therapy, Nat. Med, vol.24, pp.541-550, 2018.

P. Broz, J. Von-moltke, J. W. Jones, R. E. Vance, and D. M. Monack, Differential requirement for caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing, Cell Host Microbe, vol.8, pp.471-483, 2010.

P. Chen, W. Roh, A. Reuben, Z. A. Cooper, C. N. Spencer et al., Analysis of immune signatures in longitudinal tumor samples yields insight into biomarkers of response and mechanisms of resistance to immune checkpoint blockade, Cancer Discov, vol.6, pp.827-837, 2016.

T. Condamine, L. Le-texier, D. Howie, A. Lavault, M. Hill et al., Tmem176B and Tmem176A are associated with the immature state of dendritic cells, J. Leukoc. Biol, vol.88, pp.507-515, 2010.

K. Crozat, S. Tamoutounour, T. Vu-manh, E. Fossum, H. Luche et al., Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8+ type, J. Immunol, vol.187, pp.4411-4415, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00672203

D. Van-dijk, R. Sharma, J. Nainys, K. Yim, P. Kathail et al., Recovering gene interactions from single-cell data using data diffusion, Cell, vol.174, pp.716-729, 2018.

V. Durai and K. M. Murphy, Functions of murine dendritic cells, Immunity, vol.45, pp.719-736, 2016.

R. Eil, S. K. Vodnala, D. Clever, C. A. Klebanoff, M. Sukumar et al., Ionic immune suppression within the tumour microenvironment limits T cell effector function, Nature, vol.537, pp.539-543, 2016.

L. Eon-kuek, M. Leffler, G. A. Mackay, and M. D. Hulett, The MS4A family: counting past 1, 2 and 3, Immunol. Cell Biol, vol.94, pp.11-23, 2016.

M. E. Schroeder, S. Russo, C. Costa, J. Hori, I. Tiscornia et al., Pro-inflammatory Ca++-activated K+ channels are inhibited by hydroxychloroquine, Sci. Rep, vol.7, p.1892, 2017.

M. M. Gaidt, T. S. Ebert, D. Chauhan, K. Ramshorn, F. Pinci et al., The DNA inflammasome in human myeloid cells is initiated by a STING-Cell death program upstream of NLRP3, Cell, vol.171, pp.1110-1124, 2017.

F. Ghiringhelli, L. Apetoh, A. Tesniere, L. Aymeric, Y. Ma et al., Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors, Nat. Med, vol.15, pp.1170-1178, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00419823

T. Gong, Y. Yang, T. Jin, W. Jiang, and R. Zhou, Orchestration of NLRP3 inflammasome activation by ion fluxes, Trends Immunol, vol.39, pp.393-406, 2018.

S. L. Hamilton, A. Yatani, K. Brush, A. Schwartz, and A. M. Brown, A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes, Mol. Pharmacol, vol.31, pp.221-231, 1987.

E. Hirata, M. R. Girotti, A. Viros, S. Hooper, B. Spencer-dene et al., Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin b1/ FAK signaling, Cancer Cell, vol.27, pp.574-588, 2015.

L. Jerby-arnon, P. Shah, M. S. Cuoco, C. Rodman, M. Su et al., A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade, Cell, vol.175, pp.984-997, 2018.

R. Karki, S. M. Man, and T. Kanneganti, Inflammasomes and cancer, Cancer Immunol. Res, vol.5, pp.94-99, 2017.

D. Laoui, J. Keirsse, Y. Morias, E. Van-overmeire, X. Geeraerts et al., The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity, Nat. Commun, vol.7, p.13720, 2016.

C. Louvet, E. Chiffoleau, M. Heslan, L. Tesson, J. Heslan et al., Identification of a new member of the CD20/FcepsilonRIbeta family overexpressed in tolerated allografts, Am. J. Transplant, vol.5, pp.2143-2153, 2005.

M. S. Mangan, E. J. Olhava, W. R. Roush, H. M. Seidel, G. D. Glick et al., Targeting the NLRP3 inflammasome in inflammatory diseases, Nat. Rev. Drug Discov, vol.17, pp.588-606, 2018.

R. Muñ-oz-planillo, P. Kuffa, G. Martínez-coló-n, B. L. Smith, T. M. Rajendiran et al., K + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter, Immunity, vol.38, pp.1142-1153, 2013.

T. Murakami, J. Ockinger, J. Yu, V. Byles, A. Mccoll et al., Critical role for calcium mobilization in activation of the NLRP3 inflammasome, Proc. Natl. Acad. Sci. U S A, vol.109, pp.11282-11287, 2012.

A. M. Newman, C. L. Liu, M. R. Green, A. J. Gentles, W. Feng et al., Robust enumeration of cell subsets from tissue expression profiles, Nat. Methods, vol.12, pp.453-457, 2015.

C. Pfirschke, C. Engblom, S. Rickelt, V. Cortez-retamozo, C. Garris et al., Immunogenic chemotherapy sensitizes tumors to checkpoint blockade therapy, Immunity, vol.44, pp.343-354, 2016.

V. A. Rathinam and K. A. Fitzgerald, Inflammasome complexes: emerging mechanisms and effector functions, Cell, vol.165, pp.792-800, 2016.

N. Riaz, J. J. Havel, V. Makarov, A. Desrichard, W. J. Urba et al., Tumor and microenvironment evolution during immunotherapy with Nivolumab, Cell, vol.171, pp.934-949, 2017.

M. Segovia, C. Louvet, P. Charnet, A. Savina, G. Tilly et al., , 2014.

, Autologous dendritic cells prolong allograft survival through Tmem176b-dependent antigen cross-presentation, Am. J. Transplant, vol.14, pp.1021-1031

P. Sharma, A. , and J. , Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential, Cell, vol.161, pp.205-214, 2015.

A. Sokolovska, C. E. Becker, W. K. Ip, V. A. Rathinam, M. Brudner et al., Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function, Nat. Immunol, vol.14, pp.543-553, 2013.

N. L. Syn, M. W. Teng, T. S. Mok, and R. A. Soo, De-novo and acquired resistance to immune checkpoint targeting, Lancet Oncol, vol.18, pp.731-741, 2017.

S. Woo, M. Fuertes, L. Corrales, S. Spranger, M. Furdyna et al., STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors, Immunity, vol.41, pp.830-842, 2014.

L. Flowjo and . N/a,

, GraphPad Prism 6

D. Van-dijk, , 2018.

. Cibersort-(newman, Cancer Cell, vol.35, pp.767-781, 2015.